Market Capitalization (Millions $) |
2 |
Shares
Outstanding (Millions) |
15,598 |
Employees |
- |
Revenues (TTM) (Millions $) |
0 |
Net Income (TTM) (Millions $) |
7 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
0 |
Nutra Pharma Corp
Nutra Pharma Corp is a biotech company focused on the research, development, and commercialization of innovative pharmaceutical products and nutraceuticals. The company is known for its development of novel treatments for neurological disorders, autoimmune diseases, and infectious diseases. Nutra Pharma's flagship product, Nyloxin, is an over-the-counter pain reliever that utilizes cobratoxin, a derivative of cobra venom, as its active ingredient. The company is also actively involved in researching and patenting new treatments derived from animal venoms, including working on a potential treatment for the Zika virus.
Company Address: 1537 NW 65th Avenue Plantation 33313 FL
Company Phone Number: 509?0911 Stock Exchange / Ticker: NPHC
|